ALPANSEAlpa Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Mon, 9 Mar · 12:08 IST

Alpa Laboratories Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Ownership Changes View source PDF

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mr. Vinit Shah, an immediate relative of the promoter/promoter group, acquired 21,940 equity shares (0.10%) of Alpa Laboratories Limited from Bakulesh Chandulal Shah HUF on 7th March 2026. The transfer was done off-market by way of a gift between immediate relatives of the promoter group, with no consideration involved. After the transfer, Vinit Shah holds 21,940 shares (0.10%) while Bakulesh Chandulal Shah HUF holds zero shares. The total promoter and promoter group shareholding in the company remains unchanged pre and post the transfer. This is a routine internal reshuffle within the promoter family structure.

Likely market impact

This is a neutral event for shareholders — it is merely a reallocation of shares within the promoter family via gift, with no change in total promoter holding and no cash transaction. It should not have any material impact on the stock price or minority shareholders.